急性小血管闭塞性卒中伴早期神经功能恶化时诱导性高血压治疗的时间窗
该回顾性研究纳入136例急性小血管闭塞性卒中伴早期神经功能恶化(END)并在END后24小时内接受诱导性高血压治疗(iHTN)的患者,发现END至iHTN时间较短与神经功能改善几率增加相关,限制性立方样条显示END后约3小时内启动iHTN的获益可能最大。
要点
- END至iHTN时间较短者更易出现早期神经功能改善(ENI)或任何神经功能改善。
- END至iHTN时间每增加10分钟,ENI的比值比为0.984(95%CI 0.970-0.997;P=0.019)。
- 限制性立方样条显示ENI的比值比在END后约3小时达到最低点。
核心结论
- 在小血管闭塞性卒中伴END的患者中,END至iHTN启动的间隔较短与神经功能改善几率增加相关,iHTN的疗效可能仅限于END后最初3小时内启动。
研究设计与样本
- 回顾性研究,2017年至2021年间筛查1062例小血管闭塞性卒中患者,纳入136例在END后24小时内接受iHTN的患者。
- END定义为美国国立卫生研究院卒中量表(NIHSS)总分增加≥2分或NIHSS运动项增加≥1分。
- 采用多因素logistic回归分析,校正人口学特征、危险因素、基线临床状态和干预相关变量,并生成限制性立方样条曲线确定END至iHTN的时间切点。
主要发现
- 患者平均年龄65.1(±12.0)岁,男性占61.0%。
- 65例(47.8%)患者出现ENI,77例(56.6%)患者出现任何神经功能改善。
- ENI患者的END至iHTN时间显著短于无ENI患者(150[49-322]分钟 vs 290[97-545]分钟;P=0.018)。
- 任何神经功能改善患者的END至iHTN时间显著短于无改善患者(150[50-315]分钟 vs 300[130-573]分钟;P=0.002)。
- END至iHTN时间每增加10分钟,ENI的比值比为0.984(95%CI 0.970-0.997;P=0.019),任何神经功能改善的比值比为0.978(95%CI 0.964-0.992;P=0.002)。
关键数值与推荐
- ENI定义为NIHSS总分下降≥2分或NIHSS运动项下降≥1分。
- 任何神经功能改善定义为NIHSS总分下降≥1分。
- 限制性立方样条曲线显示ENI的比值比在END后约3小时达到最低点。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Therapeutic-induced hypertension treatment (iHTN) is helpful for alleviating early neurological deterioration (END) in acute small vessel occlusive stroke. We examined the time parameters related to iHTN effectiveness in these patients. METHODS: We retrospectively reviewed patients with acute small vessel occlusive stroke who underwent iHTN for END, defined as an increase of ≥2 points in total National Institutes of Health Stroke Scale (NIHSS) score or ≥1 point in motor items of NIHSS. The primary outcome was an early neurological improvement (ENI; a decrease of ≥2 points in total NIHSS score or ≥1 point in motor items of NIHSS), and the secondary outcome was any neurological improvement (a decrease of ≥1 point in the total NIHSS score). We conducted a multivariable logistic regression analysis, adjusting for demographics, risk factors, baseline clinical status, and intervention-related variables. We also generated a restricted cubic spline curve for the END-to-iHTN time cutoff. RESULTS: Among the 1062 patients with small vessel occlusive stroke screened between 2017 and 2021, 136 patients who received iHTN within 24 hours from END were included. The mean age was 65.1 (±12.0) years, and 61.0% were male. Sixty-five (47.8%) patients showed ENI and 77 (56.6%) patients showed any neurological improvement. END-to-iHTN time was significantly shorter in patients with ENI (150 [49-322] versus 290 [97-545] minutes; P=0.018) or any neurological improvement (150 [50-315] versus 300 [130-573] minutes; P=0.002). A 10-minute increase in the time between END and iHTN decreased the odds of achieving ENI (odds ratio, 0.984 [95% CI, 0.970-0.997]; P=0.019) or any neurological improvement (odds ratio, 0.978 [95% CI, 0.964-0.992]; P=0.002). The restricted cubic spline curve showed that the odds ratio of ENI reached its minimum at ≈3 hours. CONCLUSIONS: Among patients with small vessel occlusive stroke with END, a shorter interval between END and the initiation of iHTN was associated with increased odds of achieving neurological improvement. The efficacy of iHTN may be limited to induction within the first 3 hours of END.
引用
- Jung HJ, Ryu JC, Joon Kim B, et al. Time Window for Induced Hypertension in Acute Small Vessel Occlusive Stroke With Early Neurological Deterioration. Stroke. 2023. PMID: 38063016. doi:10.1161/STROKEAHA.123.044334
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。